NCT04263571 (PREDICT-IVI) is a clinical trial in Anemia, sponsored by Goethe University.

Who is sponsoring NCT04263571?

NCT04263571 is sponsored by Goethe University.

What condition does NCT04263571 study?

NCT04263571 studies Anemia, IV Iron.

Is NCT04263571 still recruiting?

NCT04263571 is currently status unknown. Last updated 8 October 2021.

Last reviewed 2021-10-08 · How we verify

NCT04263571: PREDICT-IVI

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Hepcidin as a Predictor for the IVI Mediated Increase in Haemoglobin Levels

Status unknown Last updated 8 October 2021

What this trial tests

trial in Anemia in 100 participants. Status unknown.

Timeline

12 April 2019

Primary endpoint
31 December 2023

31 December 2023

Quick facts

Lead sponsor	Goethe University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	100
Start date	12 April 2019
Primary completion	31 December 2023
Estimated completion	31 December 2023
Sites	2 locations across Germany

Conditions studied

Anemia — all drugs for Anemia →
IV Iron — all drugs for IV Iron →

Sponsor

Goethe University

Who can join

18 and older, any sex, with Anemia or IV Iron. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study is a multidisciplinary study, which involves all kind of medical specialties. Patients, who are scheduled for elective surgery, will be seen at a multidisciplinary anaesthesia/Patient Blood Management (PBM) clinic and screened for anaemia prior to surgery. Anaemic patients will eventually be treated with 500mg of iron isomaltoside.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Anemia

Currently open trials in the same condition.

NCT07422480 — A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myel · Phase 3 · recruiting
NCT06968936 — Long-term Outcomes Sub-Study of Preoperative Combined Iron Therapy · NA · recruiting
NCT07328191 — Quality of Life-Guided Transfusion in Refractory MDS or AML · NA · recruiting
NCT07315295 — Maximizing the Benefits of Iron in Ready-to-Use Therapeutic Foods for Malnourished Children in Kenya · NA · recruiting
NCT07400796 — Assessing Health System Readiness for Scaling Antenatal MMS in Cambodia · recruiting

Other Goethe University trials

Trials by the same sponsor.

NCT07422844 — Dynamic Network Response to TMS Treatment · recruiting
NCT07008261 — Robot-assisted Cystectomies With Regard to Blood Loss, Pain and Transfusions. · recruiting
NCT06879184 — Cohort of the Specialist Network Infectious Diseases · not yet recruiting
NCT06201936 — EPIDURAL- Evaluation of Preexisting Information Regarding Neuroaxial Procedures for Labour Analgesia · recruiting
NCT06627140 — Expected and Actual Preterm-Birth and Parental Distress: Impact on Children's Mental Health · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04263571 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Goethe University
Last refreshed: 8 October 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04263571.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing